Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Biological Psychiatry

• Publication date

  1983-10-01

• Fields of study

  Medicine, Psychology

• Identifiers
  PMID 6197099
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bromocriptine in the treatment of the alcohol‐withdrawal syndrome

  1982cited by this paper
• CSF levels of norepinephrine during alcohol withdrawal.

  1981cited by this paper
• Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in chronic schizophrenic patients with tardive dyskinesia or drug-induced tremor.

  1979cited by this paper
• Alterations in beta-adrenergic receptor binding during ethanol withdrawal.

  1978cited by this paper
• Biochemical investigations into the alcoholic delirium: Alterations of biogenic amines

  1977cited by this paper
• Cerebrospinal fluid homovanillic acid in male alcoholics: effects of disulfiram.

  1977cited by this paper
• Concentration gradients of monoamine metabolites in human cerebrospinal fluid.

  1975cited by this paper
• CHANGES IN MONOAMINE CONCENTRATIONS IN MOUSE BRAIN ASSOCIATED WITH ETHANOL DEPENDENCE AND WITHDRAWAL

  1974cited by this paper
• Effects of ethanol on central and peripheral noradrenergic neurons.

  1974cited by this paper
• Turnover rates and steady-state levels of brain serotonin in alcohol-dependent rats.

  1974cited by this paper
• Simulated behavior states: an approach to specificity in psychobiological research.

  1973cited by this paper
• Adrenal Function and Alcoholism: II. Catecholamines

  1971cited by this paper
• Urinary norepinephrine and epinerphrine excretion in delirium tremens.

  1960cited by this paper
• Effects of single doses and chronic administration of ethanol on experimental seizures in mice.

  1958cited by this paper

• Auricular transcutaneous vagus nerve stimulation for alcohol use disorder: A chance to improve treatment?

  2022cites this paper
• Plasma 5‐HIAA activity indicative of serotonergic disturbances in cognitively impaired, elderly patients experiencing postoperative delirium

  2021cites this paper
• Genetic Variation in the Vesicular Monoamine Transporter 1 (VMAT1/SLC18A1) Gene and Alcohol Withdrawal Severity.

  2016cites this paper
• Resting‐state functional connectivity and presynaptic monoamine signaling in Alcohol Dependence

  2015cites this paper
• The Role of Neurotransmitter Systems in Eating and Substance Use Disorders

  2014cites this paper
• Delirium in neurological patients

  2012cites this paper
• Neurobiology of dysregulated motivational systems in drug addiction.

  2010cites this paper
• Neuroleptic malignant syndrome and its controversies

  2010cites this paper
• Dopaminstoffwechsel bei Abhängigkeitserkrankungen: eine serologische Verlaufsuntersuchung

  2010cites this paper
• Brain stress systems in the amygdala and addiction.

  2009cites this paper
• Approach to the genetics of alcoholism: a review based on pathophysiology.

  2008cites this paper
• Pathoetiological model of delirium: a comprehensive understanding of the neurobiology of delirium and an evidence-based approach to prevention and treatment.

  2008cites this paper
• Cerebrospinal fluid homovanillic acid is correlated to psychotic features in neurological patients with delirium.

  2008cites this paper
• Ethanol withdrawal symptoms and ethanol-induced neuropathology- effects of dexmedetomidine treatment and aging

  2006cites this paper
• DBH*444G/A polymorphism of the dopamine-β-hydroxylase gene is associated with alcoholism but not with severe alcohol withdrawal symptoms

  2006cites this paper
• Association of the dopamine transporter gene with alcoholism.

  2005cites this paper
• Lower CSF Homovanillic Acid Levels in Depressed Patients with a History of Alcoholism

  2003cites this paper
• Plasma Homovanillic Acid: A Significant Association with Alcoholism is Independent of a Functional Polymorphism of the Human Catechol-O-Methyltransferase Gene

  2003cites this paper
• Changes in plasma noradrenaline and serotonin levels and craving during alcohol withdrawal.

  2003cites this paper
• 5-Hydroxyindolacetic acid and homovanillic acid are not involved in the cerebrospinal fluid after a seizure in patients with Delirium Tremens

  2002cites this paper
• A genotype-controlled analysis of plasma dopamine beta-hydroxylase in healthy and alcoholic subjects: evidence for alcohol-related differences in noradrenergic function.

  2002cites this paper
• The urinary MHPG/creatinine ratio and its relationship to platelet monoamine oxidase activity in abstinent alcoholics

  1999cites this paper
• Role of dopamine mesolimbic system in opioid action of psychotropic analgesic nitrous oxide in alcohol and drug withdrawal.

  1996cites this paper
• A review of the effects of moderate alcohol intake on the treatment of anxiety and mood disorders.

  1996cites this paper
• Alcohol withdrawal and dopamine receptor sensitivity after prolonged abstinence.

  1996cites this paper
• Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects.

  1996cites this paper
• Mean genes and the biology of aggression: a critical review of recent animal and human research.

  1996cites this paper
• Pharmacotherapy and Pathophysiology of Alcohol Withdrawal

  1995cites this paper
• Concurrent cocaine withdrawal is associated with reduced severity of alcohol withdrawal.

  1995cites this paper
• Psychotropic analgesic nitrous oxide and neurotransmitter mechanisms involved in the alcohol withdrawal state.

  1994cites this paper
• Serotonin and alcohol intake, abuse, and dependence: clinical evidence.

  1994cites this paper
• Norepinephrine metabolite in CSF correlates with ethanol consumption and heredity in humans.

  1993cites this paper
• Pathophysiologie der Alkoholpsychosen

  1993cites this paper
• Clinical and Neurochemical Aspects of Diseases with Cognitive Impairment

  1992cites this paper
• Alpha-2-adrenoceptor sensitivity in early alcohol withdrawal.

  1992cites this paper
• Plasma MHPG and age in detoxified alcoholics.

  1990cites this paper
• The drug management of severe alcohol withdrawal syndrome.

  1990cites this paper
• Human CRH stimulation response during acute withdrawal and after medium-term abstention from alcohol abuse.

  1989cites this paper
• The pentylenetetrazol-like interoceptive stimulus produced by ethanol withdrawal is potentiated by bicuculline and picrotoxinin.

  1989cites this paper
• Alcohol withdrawal: a review of clinical management.

  1989cites this paper
• Cerebro-spinal fluid studies in alcoholics and violent offenders

  1988cites this paper
• New vistas in chronic schizophrenia.

  1988cites this paper
• Mechanisms of alcohol withdrawal syndrome.

  1987cites this paper
• Identification of alcohol abuse and alcoholism with biological parameters.

  1986cites this paper
• Serum prolactin correlates with depressed mood during alcohol withdrawal.

  1986cites this paper
• Clinical neuroendocrinology and neuropharmacology of alcohol withdrawal.

  1986cites this paper
• Cerebrospinal fluid 3-methoxy-4-hydroxyphenylglycol and norepinephrine levels in alcohol withdrawal. Correlations with clinical signs.

  1985cites this paper
• The role of the central noradrenergic nervous system in the mediation of the ethanol intoxication and ethanol withdrawal syndrome.

  1984cites this paper